Form 4: Xylem Inc. President and CEO Matthew Pine Awarded Stock Options and Restricted Stock Units
SEC Form 4
Matthew Pine, President and CEO of Xylem Inc., received an award of stock options and restricted stock units on March 5, 2025.
Summary
- On March 5, 2025, Matthew Pine, President and CEO of Xylem Inc., was granted 49,392 non-qualified stock options with an exercise price of $129.67.
- These options vest in one-third increments on March 5, 2026, March 5, 2027, and March 5, 2028, and expire on March 5, 2035.
- Pine also received 14,074 restricted stock units, which vest in one-third increments on March 5, 2026, March 5, 2027, and March 5, 2028.
- Following these transactions, Pine directly owns 58,199 shares of Xylem Inc. common stock.
- The awards were made pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, which is generally viewed neutrally to positively as it aligns management with shareholder interests. The sentiment is moderately positive.
Positives
- The grant of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term performance and retention of the executive.
Industry Context
Executive compensation packages including stock options and restricted stock units are common in publicly traded companies to incentivize performance and align management's interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in companies of similar size and industry to Xylem, such as Pentair and IDEX Corporation.
- The vesting schedules are also standard, often spread over three to four years to encourage long-term commitment.
Stakeholder Impact
- Shareholders: The grant of stock options and restricted stock units can potentially increase shareholder value if the executive's performance leads to company growth.
- Employees: The compensation package can serve as a motivator for other employees, as it demonstrates the company's commitment to rewarding performance.
Key Dates
| Date | Description |
|---|---|
| February 24, 2016 | Date the Xylem 2011 Omnibus Incentive Plan was Amended and Restated |
| March 5, 2025 | Date of the transaction: grant of stock options and restricted stock units |
| March 5, 2026 | First vesting date for both stock options and restricted stock units |
| March 5, 2027 | Second vesting date for both stock options and restricted stock units |
| March 5, 2028 | Third vesting date for both stock options and restricted stock units |
| March 5, 2035 | Expiration date for the non-qualified stock options |
| March 06, 2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.